tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Westenberg, 143 are a BUY (62.72%), 79 are a HOLD (34.65%), 6 are a SELL (2.63%).
Analyst David Westenberg, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 62.79% that have a potential upside of 20.62% achieved within 139 days.
David Westenberg’s has documented 461 price targets and ratings displayed on 25 stocks. The coverage is on Healthcare, Financial Services sectors.
Most recent stock forecast was given on DGX, Quest Diagnostics at 27-Oct-2025.
Analyst best performing recommendations are on OCX (ONCOCYTE CORP).
The best stock recommendation documented was for OCX (ONCOCYTE CORP) at 11/13/2023. The price target of $3 was fulfilled within 1 day with a profit of $0.24 (8.7%) receiving and performance score of 86.96.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$21
$-1.45 (-6.46%)
$23
3 months ago
(04-Aug-2025)
7/14 (50%)
$2.64 (14.38%)
111
Buy
$25
$2.55 (11.36%)
$45
5 months 30 days ago
(05-May-2025)
0/2 (0%)
$5.44 (27.81%)
Hold
$27
$4.55 (20.27%)
$25
1 years 2 months 30 days ago
(05-Aug-2024)
1/6 (16.67%)
$3.33 (14.07%)
156
Buy
$125
$102.55 (456.79%)
$141
3 years 9 months 10 days ago
(25-Jan-2022)
3/7 (42.86%)
$61.5 (96.85%)
87
Buy
$140
$117.55 (523.61%)
$140
4 years 2 months 25 days ago
(10-Aug-2021)
6/9 (66.67%)
$42.66 (43.83%)
90
Which stock is David Westenberg is most bullish on?
Which stock is David Westenberg is most reserved on?
What Year was the first public recommendation made by David Westenberg?
